Following a rout in technology stocks on Wall Street that subdued global investor sentiments, on Monday, European shares rebounded with investors keeping a close eye on COVID-19 vaccine developments.

Australia is likely to receive its first batches of a potential COVID-19 vaccine in January 2021 after striking a manufacturing deal with CSL, which will make two vaccines – one developed by AstraZeneca and the other by Oxford University.

With the news reaching the market, AstraZeneca’s shares rose by 1.5%.

The European healthcare sector index also rose by 0.9%.

At 0709 GMT, the STOXX 600 index also jumped by 0.8%.

Shares of insurance companies, automakers and banks rose by 1% in early trading.

Categories: Creativity, Economy & Finance, Entrepreneurship, HR & Organization, Strategy

Tags: AstraZeneca, automakers, banks, COVID-19, CSL, developments, Europe, European, European healthcare sector, index, insurance, investor, investors, manufacturing deal, Oxford University, sentiments, shares, stocks, STOXX 600, technology stocks, vaccine, vaccines, Wall Street